Finance

The company's revenue increased in Q2 of this year to $13.1 million compared to $10.7 million in the first quarter – still below the $18.3 million reported in Q2 2022.

The company also announced its intentions to seek FDA approval for EndeavorOTC, its over-the-counter product for adults with ADHD.

Medicare Advantage insurtech company Clover Health and virtual care company Hims & Hers Health also reported earnings.

The Tennessee-based company has regained compliance with the bid price requirement to remain listed on the NASDAQ.

The company also seeks to sell its U.K. business to third parties, exit the U.S. market and continue trying to sell Meritage Medical Network.

The company reported second-quarter revenue of $18.5 million with a net loss of $28.7 million, alongside operating expenses totaling $42.2 million.

Informa Markets will manage the massive health technology conference, while HIMSS will continue overseeing content and programming.

Leaders from both organizations discuss the motivations behind and the goals of Informa Markets' deal to manage the HIMSS Global Health Conference and Exhibition.

The purchase comes on the heels of the surgical navigation platform's $82.5 million Series D raise in June.

Niall O'Connor, chief technology officer at Cohere Health, discusses how AI and machine learning can help streamline the prior authorization process by analyzing the totality of patient information and reducing denials by health plans.